Atea Pharmaceuticals, Inc.
AVIR· Nasdaq
Released May 12, 2025, after the close
10-Q filed May 12, 2025, 42 days after period end · 0000950170-25-069367
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Net Income | -$34.27M | -$63.17M | -$35.47M | -$42.08M |
| EPS Diluted | -$0.40 | -$0.75 | -$0.43 | -$0.51 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Atea Pharmaceuticals, Inc. · CIK 1593899 · Engraved from SEC EDGAR